Management options for metastatic melanoma in the era of novel therapies: A primer for the practicing dermatologist: Part I: Management of stage III disease
- 31 January 2013
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 68 (1), 1.e1-1.e9
- https://doi.org/10.1016/j.jaad.2012.09.040
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Guidelines of care for the management of primary cutaneous melanomaJournal of the American Academy of Dermatology, 2011
- Sentinel lymph node biopsy and melanoma: 2010 update: Part IIJournal of the American Academy of Dermatology, 2010
- Sentinel lymph node biopsy and melanoma: 2010 update: Part IJournal of the American Academy of Dermatology, 2010
- Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus MacrometastasesJournal of Clinical Oncology, 2010
- Economic Burden of Melanoma in the Elderly PopulationArchives of Dermatology, 2010
- Final Version of 2009 AJCC Melanoma Staging and ClassificationJournal of Clinical Oncology, 2009
- Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma?Cancer, 2009
- Sentinel-Node Biopsy or Nodal Observation in MelanomaThe New England Journal of Medicine, 2006
- The role of sentinel lymph node biopsy for melanoma: Evidence assessmentJournal of the American Academy of Dermatology, 2006
- An estimate of the annual direct cost of treating cutaneous melanomaJournal of the American Academy of Dermatology, 1998